FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1499 May 20, 1993 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Schneider et al. (Dec. 24 issue)¹ concluded that a single dose (either 480 mg or 960 mg) of trimethoprim-sulfamethoxazole once a day is superior to aerosolized pentamidine once a month for the prevention of Pneumocystis carinii pneumonia (PCP) in patients with human immunodeficiency virus (HIV) infection.

All the patients had comparable base-line CD4 cell counts. The authors do not report CD4 cell counts for the follow-up period. Zidovudine,^2,3,4 which was used by many patients in this study, may increase the CD4 cell count and therefore diminish the risk of PCP. In the three groups of patients, were . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.